Yi, Z. (2024). Inhibition of integrin receptor by increasing concentrations and treatment durations with Cilengitide increases the sensitivity of killing in vivo of U87 glioma cancer cell xenograft mouse. MedScien, 2(1), 382. https://doi.org/10.61173/hsv29020